cp 93129 has been researched along with fg 9041 in 2 studies
| Studies (cp 93129) | Trials (cp 93129) | Recent Studies (post-2010) (cp 93129) | Studies (fg 9041) | Trials (fg 9041) | Recent Studies (post-2010) (fg 9041) |
|---|---|---|---|---|---|
| 109 | 0 | 11 | 812 | 0 | 122 |
| Protein | Taxonomy | cp 93129 (IC50) | fg 9041 (IC50) |
|---|---|---|---|
| Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | Rattus norvegicus (Norway rat) | 0.998 | |
| Chain A, Glutamate Receptor Subunit 2 | Rattus norvegicus (Norway rat) | 0.998 | |
| Chain B, Glutamate Receptor Subunit 2 | Rattus norvegicus (Norway rat) | 0.998 | |
| fatty acid synthase | Homo sapiens (human) | 7.755 | |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 5.1 | |
| Glutamate receptor 1 | Homo sapiens (human) | 1.51 | |
| Glutamate receptor 2 | Homo sapiens (human) | 1.51 | |
| Glutamate receptor 3 | Homo sapiens (human) | 1.51 | |
| Glutamate receptor 4 | Homo sapiens (human) | 1.51 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 5.1 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 5.1 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 5.1 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 5.1 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 5.1 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 5.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akasu, T; Hasuo, H; Matsuoka, T | 1 |
| Bramley, JR; Dudek, FE; Pickard, GE; Sollars, PJ | 1 |
2 other study(ies) available for cp 93129 and fg 9041
| Article | Year |
|---|---|
5-Hydroxytryptamine 1B receptors mediate presynaptic inhibition of monosynaptic IPSC in the rat dorsolateral septal nucleus.
Topics: Analysis of Variance; Animals; Benzamides; Biphenyl Compounds; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; In Vitro Techniques; Male; Membrane Potentials; Muscimol; Neural Inhibition; Neurons; omega-Agatoxin IVA; omega-Conotoxin GVIA; Oxadiazoles; Patch-Clamp Techniques; Pertussis Toxin; Phosphinic Acids; Piperazines; Presynaptic Terminals; Propanolamines; Pyridines; Pyrroles; Quinoxalines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Septal Nuclei; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Synaptic Transmission | 2004 |
5-HT1B receptor-mediated presynaptic inhibition of GABA release in the suprachiasmatic nucleus.
Topics: Animals; Bicuculline; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; In Vitro Techniques; Male; Membrane Potentials; Mice; Mice, Knockout; Neural Inhibition; Neurons; Patch-Clamp Techniques; Presynaptic Terminals; Pyridines; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Serotonin Receptor Agonists; Suprachiasmatic Nucleus; Tetrodotoxin; Time Factors; Valine | 2005 |